Literature DB >> 30819786

Hospital Volume Versus Good Clinical Practice.

Vicente Valenti1.   

Abstract

This letter to the editor comments on a recently published article that assessed the treatment of patients with soft tissue sarcoma in high‐volume versus low‐volume centers.

Mesh：

Year:  2019        PMID： 30819786      PMCID： PMC6656498          DOI： 10.1634/theoncologist.2019-0028

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


  2 in total

1.  Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Authors:  Ian Judson; Jaap Verweij; Hans Gelderblom; Jörg T Hartmann; Patrick Schöffski; Jean-Yves Blay; J Martijn Kerst; Josef Sufliarsky; Jeremy Whelan; Peter Hohenberger; Anders Krarup-Hansen; Thierry Alcindor; Sandrine Marreaud; Saskia Litière; Catherine Hermans; Cyril Fisher; Pancras C W Hogendoorn; A Paolo dei Tos; Winette T A van der Graaf
Journal:  Lancet Oncol       Date:  2014-03-05       Impact factor: 41.316

2.  Improving Long-Term Outcomes for Patients with Extra-Abdominal Soft Tissue Sarcoma Regionalization to High-Volume Centers, Improved Compliance with Guidelines or Both?

Authors:  Sanjay P Bagaria; Yu-Hui Chang; Richard J Gray; Jonathan B Ashman; Steven Attia; Nabil Wasif
Journal:  Sarcoma       Date:  2018-04-03
  2 in total
  1 in total

1.  In Reply.

Authors:  Javier Martin-Broto; Nadia Hindi
Journal:  Oncologist       Date:  2019-03-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.